Genetic Basis of Hemangiomas

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2013 by Medical College of Wisconsin
Sponsor:
Collaborator:
Children's Hospital and Health System Foundation, Wisconsin
Information provided by (Responsible Party):
Beth Drolet, Medical College of Wisconsin
ClinicalTrials.gov Identifier:
NCT00466375
First received: April 25, 2007
Last updated: November 25, 2013
Last verified: November 2013
  Purpose

The purpose of this study is to determine if there are genes that are common in children with infantile hemangioma. This information will allow physicians to improve care for patients who have been diagnosed with this disease and to provide their parents with more complete information regarding the cause of this disease. This research is being done because many unanswered questions remain regarding children with infantile hemangioma. There are very few medications to treat infants with hemangiomas.


Condition Intervention
Hemangioma, Vascular Anomalies
Genetic: Cheek cell samples or blood sample (4mL)
Genetic: Cheek cell sample or blood sample (4mL)

Study Type: Observational
Study Design: Observational Model: Family-Based
Official Title: Genetic Basis of Hemangiomas

Resource links provided by NLM:


Further study details as provided by Medical College of Wisconsin:

Primary Outcome Measures:
  • SNP [ Time Frame: 3 years ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples With DNA

Buccal smear (cheek cells)or small blood sample (4 mL or one teaspoon)


Estimated Enrollment: 3000
Study Start Date: April 2007
Estimated Study Completion Date: May 2016
Estimated Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
A
Patients with a hemangioma.
Genetic: Cheek cell samples or blood sample (4mL)
DNA will be extracted from cheek cell or blood samples from parents and child having hemangioma.
B.
Patients with a vascular anomaly.
Genetic: Cheek cell sample or blood sample (4mL)
DNA will be extracted from cheek cell or blood samples of parents and child with a vascular anomaly.

Detailed Description:

WHAT IS INVOLVED IN THE RESEARCH STUDY?

  • Buccal smear (cheek cells) or small blood sample (4 mL or 1 teaspoon) from child being seen in the Dermatology clinic having infantile hemangioma or vascular anomaly
  • Buccal smear (cheek cells) or small blood sample (4 mL or 1 teaspoon) from parents of child

If you and your child agree to be in this study, the following will happen:

  1. Informed consent and permission to use or disclose your/your child's health information for research purposes will be obtained by Dr. Drolet, the principal investigator, or her research team. You will receive a copy of this consent form.
  2. A buccal swab or blood sample will be obtained from you and your child; buccal sampling involves rubbing the inside of your cheek and removing cells to perform a genetic test called "Genomewide Association (GWA).

We expect you and your child to be involved in this study until you and your child have the genetic testing performed.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Clinics from Children's Hospital of Wisconsin.

Criteria

Study Population Inclusion Criteria:

  • No limit to age
  • Diagnosis of infantile hemangioma and/or vascular anomaly
  • Unaffected twin sibling
  • Each patient's authorized legal guardian must understand the nature of the study and must provide written informed consent. Each patient must also give assent to study participation.

Study Population Exclusion Criteria:

  • Diagnosis other than infantile hemangioma or vascular anomaly
  • If the lesion has resolved and cannot be confirmed as a hemangioma by clinical exam
  • If the biologic parents are unwilling or unable to submit DNA samples the child will be excluded from the DNA study. Therefore, if DNA samples cannot be or are not obtained from both biologic parents, the child and family will be excluded from the study.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00466375

Contacts
Contact: Shawna Joachim, B.A. 414-955-2817 sjoachim@mcw.edu
Contact: Beth Drolet, MD 414-955-2818 bdrolet@mcw.edu

Locations
United States, Wisconsin
Children's Hospital of Wisconsin Recruiting
Milwaukee, Wisconsin, United States, 53226
Sponsors and Collaborators
Medical College of Wisconsin
Children's Hospital and Health System Foundation, Wisconsin
Investigators
Principal Investigator: Beth Drolet, MD Medical College of Wisconsin
  More Information

No publications provided

Responsible Party: Beth Drolet, Professor and Vice Chairman of Pediatric Dermatology, Medical College of Wisconsin
ClinicalTrials.gov Identifier: NCT00466375     History of Changes
Other Study ID Numbers: Genetics of Hemangioma
Study First Received: April 25, 2007
Last Updated: November 25, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by Medical College of Wisconsin:
hemangioma
vascular anomaly
infantile hemangioma

Additional relevant MeSH terms:
Congenital Abnormalities
Hemangioma
Vascular Malformations
Neoplasms, Vascular Tissue
Neoplasms by Histologic Type
Neoplasms
Cardiovascular Abnormalities
Cardiovascular Diseases

ClinicalTrials.gov processed this record on July 29, 2014